European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC)…
Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Hillary Bochniak as Chief Human Resources…
Medicines and Healthcare Products Regulatory Agency authorizes G SK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for older adults GSK plc (LSE/NYSE: GSK) today announced that the Medicines and…
Unlocking the mystery of long-lasting cancer treatmentUnlocking the mystery of long-lasting cancer treatment New insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell…
Artificial cells demonstrate that “life finds a way” Listen, if there’s one thing the history of evolution has taught us is that life will not be contained. Life breaks free.…
Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023 Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today…
Women and girls bear brunt of water and sanitation crisis – new UNICEF-WHO report Globally, women are most likely to be responsible for fetching water for households, while girls are…
Syneos Health Strengthens Asia Pacific Leadership Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Shigeto Miyamoto as Vice President of Digital Solutions for Asia Pacific. In…
WHO Regional Adviser for Prevention and response to sexual misconduct in South-East Asia Anju Pandey is a feminist, humanist and gender trainer. She joined WHO’s Regional Office for South-East Asia…
The new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called…
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency NEW YORK & MIAMI–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today…
AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health AstraZeneca has announced a $400 million investment in its global AZ Forest programme,…